Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02735473 · ClinicalTrials.gov registry record · Phase 2
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders
A Phase 2 study of Fetal Alcohol Spectrum Disorders, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT02735473: Completed Phase 2 study of Fetal Alcohol Spectrum Disorders, sponsored by University of Minnesota.
NCT02735473 is a Phase 2 study of Fetal Alcohol Spectrum Disorders that has completed, run by University of Minnesota. The registered enrollment target is 46 participants, below the 102-participant average among 10 other Fetal Alcohol Spectrum Disorders trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02735473, a Phase 2 study of Fetal Alcohol Spectrum Disorders, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, double-blind, placebo-controlled trial of choline supplementation in children with Fetal Alcohol Spectrum Disorders (FASD). The primary outcome measures are cognitive measures.
Primary Outcome
Elicited Imitation memory paradigm - short delay memory measure at 6 months; scores are in percentage correct.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Choline bitartrate
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2016-06 |
| Est. Completion | 2021-09-10 |
| Phase | Phase 2 |
What the finished NCT02735473 record still lists
NCT02735473 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 102-participant average among 10 other Fetal Alcohol Spectrum Disorders trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Fetal Alcohol Spectrum Disorders appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02735473 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02735473 about?
NCT02735473 is a clinical study titled "Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders". This is a randomized, double-blind, placebo-controlled trial of choline supplementation in children with Fetal Alcohol Spectrum Disorders (FASD). The primary outcome measures are cognitive measures.
What is the current status of trial NCT02735473?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2016-06. Estimated completion is 2021-09-10.
What conditions does trial NCT02735473 study?
This clinical trial studies the following conditions: Fetal Alcohol Spectrum Disorders.
What interventions are being tested in trial NCT02735473?
The interventions under investigation include: Placebo (DRUG), Choline bitartrate (DRUG).
Who is sponsoring clinical trial NCT02735473?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02735473 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fetal Alcohol Spectrum Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02735473's enrollment target sits among peer trials
46 8th of 10 higher than 3 of 10 other Fetal Alcohol Spectrum Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fetal Alcohol Spectrum Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study
ACTIVE NOT RECRUITING · Phase 2
-
The Oklahoma Parent-Child Assistance Program
RECRUITING · NA
-
CIFASD 5 tDCS and Cognitive Training
RECRUITING · NA
-
Families Moving Forward (FMF) Connect Pro for Mental Health Providers
RECRUITING · NA
-
The Synchrony Study: Examining Music Training for Children With FASD
RECRUITING · NA
-
Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia